> top > docs > PMC:7205724 > spans > 118-382 > annotations

PMC:7205724 / 118-382 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3 134-141 Species denotes patient Tax:9606
5 213-221 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 14-29 Body_part denotes immunoglobulins http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 213-221 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T2 35-50 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T3 103-118 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T4 166-181 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T1 14-29 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes immunoglobulins http://purl.bioontology.org/ontology/MEDDRA/10021496

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 35-50 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T2 103-118 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T3 166-181 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T2 213-221 Species denotes COVID-19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T4 52-62 Sentence denotes Highlights
T5 63-151 Sentence denotes • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.
T6 152-222 Sentence denotes • The use of corticosteroids might accelerate recovery from COVID-19.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
3 134-141 Species denotes patient Tax:9606
5 213-221 Disease denotes COVID-19 MESH:C000657245

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T18 12-13 -COMMA- denotes ,
T19 14-29 NNS denotes immunoglobulins
T20 29-30 -COMMA- denotes ,
T21 31-34 CC denotes and
T22 35-50 NNS denotes corticosteroids
T23 52-62 NNS denotes Highlights
T24 63-64 IN denotes •
T25 66-70 NNP denotes IVIG
T26 70-71 -COMMA- denotes ,
T27 72-80 VBN denotes combined
T28 81-85 IN denotes with
T29 86-99 NN denotes moderate-dose
T30 100-102 IN denotes of
T31 103-118 NNS denotes corticosteroids
T32 118-119 -COMMA- denotes ,
T33 120-125 MD denotes might
T34 126-133 VB denotes improve
T35 134-141 NN denotes patient
T36 142-150 NNS denotes outcomes
T37 152-153 PDT denotes •
T38 155-158 DT denotes The
T39 159-162 NN denotes use
T40 163-165 IN denotes of
T41 166-181 NNS denotes corticosteroids
T42 182-187 MD denotes might
T43 188-198 VB denotes accelerate
T44 199-207 NN denotes recovery
T45 208-212 IN denotes from
T46 213-221 NN denotes COVID-19
T47 223-224 PDT denotes •
T48 226-228 DT denotes No
T49 229-239 VBN denotes controlled
T50 240-248 JJ denotes clinical
T51 249-255 NNS denotes trials
T52 256-261 VBP denotes exist
T53 262-264 IN denotes on
R16 T19 T18 arg2Of immunoglobulins,","
R17 T21 T20 arg1Of and,","
R18 T18 T21 arg1Of ",",and
R19 T22 T21 arg2Of corticosteroids,and
R20 T25 T24 arg1Of IVIG,•
R21 T25 T26 arg1Of IVIG,","
R22 T25 T27 arg2Of IVIG,combined
R23 T27 T28 arg1Of combined,with
R24 T29 T28 arg2Of moderate-dose,with
R25 T29 T30 arg1Of moderate-dose,of
R26 T31 T30 arg2Of corticosteroids,of
R27 T34 T32 arg1Of improve,","
R28 T25 T33 arg1Of IVIG,might
R29 T34 T33 arg2Of improve,might
R30 T25 T34 arg1Of IVIG,improve
R31 T36 T34 arg2Of outcomes,improve
R32 T36 T35 arg1Of outcomes,patient
R33 T39 T37 arg1Of use,•
R34 T39 T38 arg1Of use,The
R35 T39 T40 arg1Of use,of
R36 T41 T40 arg2Of corticosteroids,of
R37 T39 T42 arg1Of use,might
R38 T43 T42 arg2Of accelerate,might
R39 T39 T43 arg1Of use,accelerate
R40 T44 T43 arg2Of recovery,accelerate
R41 T44 T45 arg1Of recovery,from
R42 T46 T45 arg2Of COVID-19,from
R43 T51 T47 arg1Of trials,•
R44 T51 T48 arg1Of trials,No
R45 T51 T49 arg2Of trials,controlled
R46 T51 T50 arg1Of trials,clinical
R47 T51 T52 arg1Of trials,exist
R48 T52 T53 arg1Of exist,on

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T1 14-29 Body_part denotes immunoglobulins http://purl.org/sig/ont/fma/fma62871

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 213-221 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T4 52-62 Sentence denotes Highlights
T5 63-151 Sentence denotes • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.
T6 152-222 Sentence denotes • The use of corticosteroids might accelerate recovery from COVID-19.